Advanced ScienceVolume 11, Issue 23 2470136 Inside Back CoverOpen Access EZH2 Inhibition Enhances PD-L1 Protein Stability Through USP22-Mediated Deubiquitination in Colorectal Cancer (Adv. Sci. 23/2024) Jiaqi Huang, Jiaqi HuangSearch for more papers by this authorQianqian Yin, Qianqian YinSearch for more papers by this authorYuqing Wang, Yuqing WangSearch for more papers by this authorXin Zhou, Xin ZhouSearch for more papers by this authorYunyun Guo, Yunyun GuoSearch for more papers by this authorYuanjun Tang, Yuanjun TangSearch for more papers by this authorRui Cheng, Rui ChengSearch for more papers by this authorXiaotong Yu, Xiaotong YuSearch for more papers by this authorJie Zhang, Jie ZhangSearch for more papers by this authorChen Huang, Chen HuangSearch for more papers by this authorZhanya Huang, Zhanya HuangSearch for more papers by this authorJianlin Zhang, Jianlin ZhangSearch for more papers by this authorZhengyang Guo, Zhengyang GuoSearch for more papers by this authorXiao Huo, Xiao HuoSearch for more papers by this authorYan Sun, Yan SunSearch for more papers by this authorYanfang Li, Yanfang LiSearch for more papers by this authorHao Wang, Hao WangSearch for more papers by this authorJianling Yang, Jianling YangSearch for more papers by this authorLixiang Xue, Lixiang XueSearch for more papers by this author Jiaqi Huang, Jiaqi HuangSearch for more papers by this authorQianqian Yin, Qianqian YinSearch for more papers by this authorYuqing Wang, Yuqing WangSearch for more papers by this authorXin Zhou, Xin ZhouSearch for more papers by this authorYunyun Guo, Yunyun GuoSearch for more papers by this authorYuanjun Tang, Yuanjun TangSearch for more papers by this authorRui Cheng, Rui ChengSearch for more papers by this authorXiaotong Yu, Xiaotong YuSearch for more papers by this authorJie Zhang, Jie ZhangSearch for more papers by this authorChen Huang, Chen HuangSearch for more papers by this authorZhanya Huang, Zhanya HuangSearch for more papers by this authorJianlin Zhang, Jianlin ZhangSearch for more papers by this authorZhengyang Guo, Zhengyang GuoSearch for more papers by this authorXiao Huo, Xiao HuoSearch for more papers by this authorYan Sun, Yan SunSearch for more papers by this authorYanfang Li, Yanfang LiSearch for more papers by this authorHao Wang, Hao WangSearch for more papers by this authorJianling Yang, Jianling YangSearch for more papers by this authorLixiang Xue, Lixiang XueSearch for more papers by this author First published: 19 June 2024 https://doi.org/10.1002/advs.202470136AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Graphical Abstract Colon Cancer EZH2 inhibitor can activate the expression of deubiquitinase USP22 in colorectal cancer via canonical epigenetic regulation, thereby stabilizing PD-L1 protein and enhancing its expression, resulting in immune evasion and compromised anti-tumor efficacy. Combination with immunotherapy can overcome the immune suppressive effects of EZH2 inhibitors and achieve better outcome. More details can be found in article number 2308045 by Hao Wang, Jianling Yang, Lixiang Xue, and co-workers. Volume11, Issue23June 19, 20242470136 RelatedInformation